 Connection
Lisa Bero to Publication Bias
This is a "connection" page, showing publications Lisa Bero has written about Publication Bias.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.461 |
|
|
|
-
de Rezende LFM, Rey-L?pez JP, de S? TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L. Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. PLoS Biol. 2018 06; 16(6):e2005761.
Score: 0.640
-
Parker L, Grundy Q, Bero L. Interpreting evidence in general practice: Bias and conflicts of interest. Aust J Gen Pract. 2018 06; 47(6):337-340.
Score: 0.638
-
Bero L. Addressing Bias and Conflict of Interest Among Biomedical Researchers. JAMA. 2017 May 02; 317(17):1723-1724.
Score: 0.592
-
Mandrioli D, Kearns CE, Bero LA. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PLoS One. 2016; 11(9):e0162198.
Score: 0.566
-
Anglemyer AT, Krauth D, Bero L. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. BMC Med Res Methodol. 2015 Mar 06; 15:12.
Score: 0.510
-
Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS Biol. 2014 Jan; 12(1):e1001770.
Score: 0.471
-
Bero LA. Why the Cochrane risk of bias tool should include funding source as a standard item. Cochrane Database Syst Rev. 2013 Dec 20; (12):ED000075.
Score: 0.469
-
Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012 Jan 03; 344:d7202.
Score: 0.409
-
Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 2009 Dec 16; 10:116.
Score: 0.355
-
Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008 Nov 25; 5(11):e217; discussion e217.
Score: 0.330
-
Chartres N, Fabbri A, McDonald S, Diong J, McKenzie JE, Bero L. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2020 12 04; 10(12):e039036.
Score: 0.190
-
Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2019 05 19; 9(5):e022912.
Score: 0.170
-
Misakian AL, Bero LA. Publication bias and research on passive smoking: comparison of published and unpublished studies. JAMA. 1998 Jul 15; 280(3):250-3.
Score: 0.161
-
Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 02 16; 2:MR000033.
Score: 0.146
-
Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environ Int. 2016 Jul-Aug; 92-93:597-604.
Score: 0.134
-
Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA. 1994 Jul 13; 272(2):133-6.
Score: 0.122
-
Odierna DH, Forsyth SR, White J, Bero LA. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Account Res. 2013; 20(2):127-41.
Score: 0.110
-
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 Dec 12; 12:MR000033.
Score: 0.109
-
Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med. 2009 Nov 12; 361(20):1963-71.
Score: 0.088
-
Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007 Jun; 4(6):e184.
Score: 0.074
-
Bero LA. Managing financial conflicts of interest in research. J Am Coll Dent. 2005; 72(2):4-9.
Score: 0.063
-
Page MJ, Bero L, Kroeger CM, Dai Z, McDonald S, Forbes A, McKenzie JE. Investigation of Risk Of Bias due to Unreported and SelecTively included results in meta-analyses of nutrition research: the ROBUST study protocol. F1000Res. 2019; 8:1760.
Score: 0.044
-
Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20; 279(19):1566-70.
Score: 0.040
-
Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. BMJ. 2015 Jun 10; 350:h2613.
Score: 0.032
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|